Ma Huang Capsules
Natural health product licensed in Canada
- Other names
- Ephedra Capsules
- Licence holder
- Beijing Kingbird Pharmaceutical Technology Development Co.,Ltd.
- NPN or DIN-HM
- 80101935
- Status
- Active licence
- Licence date
- 18 June 2020
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Stéarate de magnésium, Cellulose, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Capsule | minimum: 2 Tous les jours ; maximum: 3 Tous les jours |
Uses authorised in Canada
Used in Herbal Medicine as a decongestant/to relieve nasal congestion (due to hay fever/allergic rhinitis/allergies/sinusitis/the common cold/flu).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen. Consult a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you are pregnant or breastfeeding. Consult a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you are taking medication and/or natural health products for allergy symptoms, asthma, cough/cold, or weight control. Consult a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you are taking other products containing caffeine, ephedrine, phenylpropanolamine, or pseudoephedrine. Consult a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you have a cardiovascular disease, diabetes, difficulty in urination due to prostate enlargement, glaucoma, thyroid problems, seizure disorders, or pre-existing psychiatric conditions. Keep out of the reach of children.
- Effets indésirables connus
Stop use in case of restlessness, irritability, dizziness, tremors, severe headache, insomnia, loss of appetite, nausea, rapid heartbeat, shortness of breath, and/or disturbance of urination.
- Contre-indications
Do not use this product if you are taking or have taken monoamine oxidase (MAO) inhibitors in the past two weeks.
Source
Official Health Canada record, licence 80101935
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.